MarketInOut Stock Screener Log In | Sign Up
 

Arcturus Therapeutics Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/21/2026 16:00
Arcturus Therapeutics Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization455.62 mln
Float22.85 mln
Earnings Date11/11/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-4.62
Highly reliable

1-Year Forecast

22.30
Exceptional upside

Relative Strength

18 / 100
Significantly lagging

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-498%
Severely loss-making

Business Description

Arcturus Therapeutics is a San Diego-based medicine company founded in 2013 that uses mRNA technology to create treatments for rare liver and respiratory diseases, as well as vaccines for infectious illnesses like COVID-19 and influenza. The company has developed its own delivery system to get these medicines into the body effectively, and several of its treatments are currently being tested in clinical trials. Its most advanced programs target cystic fibrosis and a rare liver disorder that prevents the body from processing certain proteins.

Key Fundamentals

EPS-3.33
ROE-45.16
RPS1.05
ROIC-162
ROA-35.00
EBITDA, mln-89.06
EV / EBITDA-2.96
EV / EBIT-2.87
Revenue, mln18.72
EV / Revenue14.06

Quote Details

Last 14.69
Change -1.34 (-8.36%)
Open 16.37
Volume 999,832
Turnover 14,687,532
Average Volume 1,257,059

Financial Ratios

Pre-Tax Profit Margin-498
Leverage Ratio1.31
Current Ratio5.88
Price / Book2.51
Price / Tangible Book2.51
Debt / Equity0.13
Price / Sales22.24

Financial Strength

Altman Z-Score0.99
Piotroski F-Score 1 / 9
Beneish M-Score-4.62
1-Year Target Price22.30
Short Ratio4.55
Short % of Float26.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.92% 16 / 100   
1 Month 33.67% 97 / 100   
2 Months 111% 99 / 100   
6 Months 122% 97 / 100   
1 Year -25.13% 25 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us